 | Corbus Pharmaceuticals (NASDAQ:CRBP) Rating Lowered to Sell at Zacks Investment Research
marketbeat.com - August 7 at 9:43 PM |
 | Corbus Pharmaceuticals (NASDAQ:CRBP) Posts Quarterly Earnings Results, Misses Expectations By $0.13 EPS
americanbankingnews.com - August 9 at 4:17 PM |
| Corbus Pharmaceuticals' (CRBP) "Buy" Rating Reiterated at HC Wainwright
americanbankingnews.com - August 8 at 12:22 AM |
| Corbus Pharmaceuticals (NASDAQ:CRBP) Trading Down 11.5%
americanbankingnews.com - August 6 at 8:58 PM |
 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 3:02 PM |
| Corbus Pharmaceuticals EPS misses by $0.14, misses on revenue
seekingalpha.com - August 6 at 10:00 AM |
 | Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
finance.yahoo.com - August 6 at 10:00 AM |
| Corbus Pharmaceuticals Completes Enrollment in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
finance.yahoo.com - August 5 at 1:50 PM |
| Brokerages Expect Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Will Post Quarterly Sales of $3.90 Million
americanbankingnews.com - August 5 at 1:40 AM |
| Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - August 4 at 2:12 AM |
|
| Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Up 8.3%
americanbankingnews.com - August 3 at 8:08 PM |
| Zacks: Brokerages Anticipate Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Will Announce Earnings of -$0.38 Per Share
americanbankingnews.com - August 3 at 6:14 PM |
| Corbus Pharmaceuticals (CRBP) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - August 1 at 10:06 PM |
| Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020
finance.yahoo.com - July 30 at 12:49 PM |
| Corbus Pharmaceuticals (NASDAQ:CRBP) Trading Down 6.3%
www.americanbankingnews.com - July 29 at 9:22 PM |
| Corbus Pharmaceuticals secures debt funding of $50M
seekingalpha.com - July 29 at 9:58 AM |
| Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital
finance.yahoo.com - July 29 at 9:58 AM |
| Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Increased to $18.00 by Analysts at Jefferies Financial Group
www.americanbankingnews.com - July 27 at 11:59 AM |
 | CRBP Dec 2020 15.000 call
uk.finance.yahoo.com - July 26 at 1:57 PM |
| CRBP Nov 2020 3.000 call
uk.finance.yahoo.com - July 26 at 1:57 PM |
| After 6 Years Corbus Shareholders Face The Ultimate Milestone: The Imminent Release Of Lenabasum's Phase 3 Data
seekingalpha.com - July 22 at 6:50 AM |
| What Does Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) CEO Pay Reveal?
finance.yahoo.com - July 15 at 5:55 PM |
| What Does Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) CEO Pay Reveal?
finance.yahoo.com - July 15 at 5:55 PM |
| Corbus Pharmaceuticals Holdings Inc (CRBP): Are Hedge Funds Right About This Stock?
finance.yahoo.com - July 5 at 10:59 PM |
 | CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock
www.nasdaq.com - July 5 at 12:22 AM |
| Corbus nearing finish line in lenabasum study in cystic fibrosis
seekingalpha.com - June 22 at 2:29 PM |
| Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
finance.yahoo.com - June 22 at 9:28 AM |
| Corbus Pharmaceuticals Announces Publication of Phase 2b Cystic Fibrosis Study Patient Demographics and Baseline Disease Characteristics in the Journal of Cystic Fibrosis
finance.yahoo.com - June 1 at 1:00 PM |
| Is Corbus Pharmaceuticals (CRBP) Stock a Solid Choice Right Now?
finance.yahoo.com - June 1 at 1:00 PM |
| Will Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Spend Its Cash Wisely?
finance.yahoo.com - May 28 at 8:28 AM |
|
| Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
finance.yahoo.com - May 27 at 12:06 PM |
| Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress
finance.yahoo.com - May 22 at 12:23 PM |
| Edited Transcript of CRBP earnings conference call or presentation 11-May-20 12:30pm GMT
finance.yahoo.com - May 17 at 11:52 PM |
| Corbus Pharmaceuticals (CRBP) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 15 at 2:14 PM |
| Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
finance.yahoo.com - May 15 at 9:13 AM |
| Do Options Traders Know Something About Corbus Pharmaceuticals (CRBP) Stock We Don't?
finance.yahoo.com - May 14 at 7:02 PM |
| Do Options Traders Know Something About Corbus Pharmaceuticals (CRBP) Stock We Don't?
www.nasdaq.com - May 14 at 2:01 PM |
| Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 5:17 PM |
| Corbus Pharmaceuticals EPS misses by $0.02, misses on revenue
seekingalpha.com - May 11 at 7:47 AM |
| Corbus Pharmaceuticals Reports First Quarter Financial Results and Corporate Updates
finance.yahoo.com - May 11 at 7:47 AM |
| Corbus announces open market sale agreement with Jefferies
seekingalpha.com - May 4 at 4:17 PM |
| Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
finance.yahoo.com - May 4 at 8:42 AM |
| Viela Bio Announces Election of Rachelle Jacques to its Board of Directors
finance.yahoo.com - April 30 at 4:44 PM |
| Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
finance.yahoo.com - April 29 at 11:55 AM |
| Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Shareholders Booked A 86% Gain In The Last Five Years
finance.yahoo.com - April 28 at 10:48 AM |
 | 3 Reasons Medical Marijuana Is a Better Long-Term Investment Than Recreational Pot
www.fool.com - April 19 at 7:51 AM |
| Implied Volatility Surging for Corbus (CRBP) Stock Options
finance.yahoo.com - April 2 at 10:53 AM |
| Edited Transcript of CRBP earnings conference call or presentation 12-Mar-20 12:30pm GMT
finance.yahoo.com - March 31 at 10:01 PM |
| RBC sees 21% upside in Danaher in premarket analyst action
seekingalpha.com - March 26 at 7:57 AM |
| Corbus Pharmaceuticals Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
finance.yahoo.com - March 14 at 12:35 PM |
| Corbus Pharma down 9% premarket on Q4 miss
seekingalpha.com - March 12 at 2:35 PM |
